Use of Dexmedetomidine in Acute Stroke and Cerebral Vasospasm Interventions


Phase 2 Results N/A

Eligibility Criteria

Inclusion Criteria

- Patients with acute ischemic stroke who require endovascular intervention with whom mNIHSS score can be obtained
- Patients with cerebral vasospasm suspiciousness with or without subarachnoid hemorrhage with whom mNIHSS score can be obtained.

Exclusion Criteria

- History of severe hepatic disease or severe renal disease (GFR<20).
- Hemodynamic instability.
- Pregnancy.
- Known allergy to study drug.
- Evidence or history of cardiac electrophysiology instability including uncontrolled hemodynamically unstable complex atrial/ventricular arrhythmia or conduction block at the time of evaluation with the exception of atrial fibrillation, and heart rate less than 60 or systolic blood pressure less than 90.
- Respiratory compromise requiring intubation.
- Any medical (including history of cardiac conduction block, major hepatic or renal disease) or laboratory abnormality that may increase the risk associated with the trial participation or drug administration or may interfere with interpretation of trial results.